International Journal of Environmental Research and Public Health · 2019 · 80 citations · 33 references
Public HealthInfectious Disease ControlPreventive MedicineHiv ControlHiv PreventionReproductive HealthPre-exposure ProphylaxisPrevention Of Sexual TransmissionSexual Health PreventionSexual Risk ReductionSexually Transmitted Infection PreventionSexually Transmitted InfectionsAwarenessDaily Oral Pre-exposure ProphylaxisHiv Pre-exposure ProphylaxisHiv Prevention UptakeLong-acting Injectable Pre-exposure ProphylaxisPre-exposure Prophylaxis AdherencePre-exposure Prophylaxis ImplementationPre-exposure Prophylaxis Uptake
This study aimed to investigate the levels of willingness to use pre-exposure prophylaxis (PrEP) and intention to adhere to PrEP and to further explore factors associated with PrEP uptake among men who have sex with men (MSM) in China. A total of 524 MSM were recruited from Chengdu, China. Half of the participants had heard of PrEP, and the awareness rate varied from 33.8%, 30.7%, and 7.1% for daily oral PrEP, on-demand PrEP, and long-acting injectable PrEP (LAI-PrEP), respectively. The overall willingness to use any type of PrEP in the next six months was 84.9% if PrEP is effective and provided for free. Participants were less likely to say that they would use PrEP if they used a condom consistently with their regular partners. However, participants were more likely to say that they would use PrEP if they had casual partners in the past month and had higher HIV prevention literacy. The majority of participants intended to adhere to PrEP prescription. More than forty percent (43.1%) of the participants reported that they might reduce condom use if they took PrEP. We found that the overall willingness to use PrEP was high among MSM living in China, but willingness varied across the different types of PrEP.
33
Jean‐Michel Molina, Isabelle Charreau, Bruno Spire et al. · The Lancet HIV · 2017 · 472 citations · Full text
Public Health, Infectious Disease Control, Preventive Medicine +16
Jeffrey T. Parsons, H. Jonathon Rendina, Jonathan Mathias Lassiter et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 309 citations
Beatriz Grinsztejn, Brenda Hoagland, Ronaldo I. Moreira et al. · The Lancet HIV · 2018 · 210 citations
Medicine, Infectious Disease Control, Preventive Medicine +17